Nanohale AG (ETR:FYB) | WebDisclosure

Basculer en Français

10108	Companies
207161	Keywords
137291	Articles
109798	Press releases

Home
Companies
Nanohale AG

PRESS RELEASE

published on 05/19/2025 at 15:00, 10 months 9 days ago

Formycon and Fresenius Kabi announce FDA Approval of Interchangeability for FYB202/Otulfi® (ustekinumab-aauz)
Formycon and Fresenius Kabi receive FDA approval for interchangeability of FYB202/Otulfi (ustekinumab-aauz) with Stelara, enhancing patient access to treatment options for inflammatory diseases in the US

FDA Approval Formycon Fresenius Kabi Biologics Interchangeability
BRIEF

published on 05/12/2025 at 06:35, 10 months 16 days ago

Formycon franchit des étapes clés au premier trimestre 2025 dans des conditions difficiles

Partenariats Stratégiques Orientation Financière Formycon T1 2025 Approbations De Biosimilaires Lancement Du FYB202
BRIEF

published on 05/12/2025 at 06:35, 10 months 16 days ago

Formycon Achieves Key Milestones in Q1 2025 Amid Challenging Conditions

Strategic Partnerships Financial Guidance Formycon Q1 2025 Biosimilar Approvals FYB202 Launch
PRESS RELEASE

published on 05/12/2025 at 06:30, 10 months 16 days ago

Formycon reports strong operational performance and financial results for first quarter of 2025
Formycon AG reports strong operational performance and financial results for the first quarter of 2025. Market approvals, revenue growth, and strategic partnerships discussed

Financial Results Operational Performance Formycon AG Biosimilars Market Approvals
BRIEF

published on 05/07/2025 at 09:42, 10 months 21 days ago

Formycon annonce sa conférence sur les résultats du premier trimestre 2025 et ses conférences avec les investisseurs

Conseil D'administration Formycon AG Conférences D'investisseurs Perspectives Financières Résultats Du Premier Trimestre 2025
BRIEF

published on 05/07/2025 at 09:42, 10 months 21 days ago

Formycon Announces Q1 2025 Results Conference and Investor Conferences

Investor Conferences Formycon AG Management Board Financial Outlook Q1 2025 Results
PRESS RELEASE

published on 05/07/2025 at 09:37, 10 months 21 days ago

Formycon invites to conference call on the results of the first quarter of 2025 and announces participation in international investor conferences
Formycon AG to discuss Q1 2025 results in a conference call and participate in investor conferences. Details and webcast link available. Biosimilar development focus

Conference Call Investor Conferences Formycon AG Biosimilars Q1 2025 Results
BRIEF

published on 03/27/2025 at 06:35, 1 year ago

Formycon AG prévoit un exercice 2024 solide et une croissance continue en 2025

Formycon AG Prévisions De Revenus Biosimilaires Exercice Financier 2024 Positionnement Sur Le Marché
BRIEF

published on 03/27/2025 at 06:35, 1 year ago

Formycon AG Sees Strong Fiscal Year 2024, Eyes Continued Growth in 2025

Market Position Revenue Forecast Financial Year 2024 Formycon AG Biosimilars
PRESS RELEASE

published on 03/27/2025 at 06:30, 1 year ago

Formycon reports on a successful financial year 2024 with strong operational progress and continuous strengthening of its market position
Formycon reports successful financial year 2024 with strong operational progress and market position enhancement. Key milestones achieved in biosimilar development. Financial outlook for 2025 provided

Market Position Financial Year 2024 Financial Outlook Biosimilar Formycon

Accesswire

Published on 03/28/2026 at 01:00, 23 hours 37 minutes ago

Battery X Metals Announces Confidential Submission of Amended Draft Registration Statement with the U.S. Securities and Exchange Commission in Connection with Proposed U.S. National Securities Exchange Initial Public Offering
Published on 03/28/2026 at 00:55, 23 hours 42 minutes ago

Notification of Relevant Change to Significant Shareholder
Published on 03/28/2026 at 00:50, 23 hours 47 minutes ago

"Rise" Selected as NASA Artemis II Moon Mascot
Published on 03/27/2026 at 22:45, 1 day 1 hour ago

Caledonia Mining Corporation Plc - Notification of Relevant Change to Significant Shareholder
Published on 03/27/2026 at 22:30, 1 day 2 hours ago

Usha Resources Completes Extended Induced Polarization Survey at the Southern Arm Property

View all ACCESSWIRE

EQS Group

Published on 03/28/2026 at 10:05, 14 hours 31 minutes ago

Hisense Advances a Quiet Green Revolution in Home Entertainment
Published on 03/28/2026 at 08:56, 15 hours 40 minutes ago

Turkiye Garanti Bankasi A.S.: Sale of Garanti Bank S.A. and our public disclosure dated 10.03.2026
Published on 03/28/2026 at 01:42, 22 hours 54 minutes ago

EQS-Adhoc: Raiffeisen Bank International AG: Agreement on the acquisition of Garanti BBVA Group Romania
Published on 03/27/2026 at 21:58, 1 day 2 hours ago

Kaufman & Broad SA: Availability of the Universal Registration Document 2025
Published on 03/27/2026 at 21:58, 1 day 2 hours ago

Kaufman & Broad SA: Mise à disposition du Document d'Enregistrement Universel 2025

Les Echos

Published on 03/28/2026 at 07:00, 17 hours 37 minutes ago

Groupe DLSI - Résultat 2025
Published on 03/27/2026 at 19:06, 1 day 5 hours ago

Mersen : Déclaration des transactions sur actions propres
Published on 03/27/2026 at 19:06, 1 day 5 hours ago

Mersen: Disclosure of trading own shares
Published on 03/27/2026 at 18:52, 1 day 5 hours ago

Crédit Agricole CIB announces the publication of its 2025 Universal Registration Document
Published on 03/27/2026 at 18:52, 1 day 5 hours ago

Crédit Agricole CIB annonce la publication de son Document d’enregistrement universel 2025

View all LES ECHOS COMFI WIRE